|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
0.34%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.34%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
0.34%
|
US
|
NASDAQ
|
|
PME
|
Pro Medicus Limited
|
0.34%
|
AU
|
ASX
|
|
GLPG
|
Galapagos NV
|
0.31%
|
NL
|
AS
|
|
IDIA
|
Idorsia Ltd
|
0.30%
|
CH
|
SW
|
|
326030
|
Sk Biopharmaceuticals Co Ltd
|
0.29%
|
KR
|
KO
|
|
CERT
|
Certara, Inc.
|
0.29%
|
US
|
NASDAQ
|
|
ABCL
|
AbCellera Biologics Inc.
|
0.28%
|
US
|
NASDAQ
|
|
RCM
|
R1 RCM Inc.
|
0.28%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
302440
|
SK Bioscience Co Ltd
|
0.26%
|
KR
|
KO
|
|
CHEMM
|
ChemoMetec A/S
|
0.26%
|
DK
|
CO
|
|
CRVL
|
CorVel Corp.
|
0.26%
|
US
|
NASDAQ
|
|
3347
|
Hangzhou Tigermed Consulting Co Ltd
|
0.26%
|
HK
|
HK
|
|
VIVO
|
Meridian Bioscience Inc.
|
0.25%
|
US
|
NASDAQ
|
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
RVMD
|
Revolution Medicines, Inc.
|
0.23%
|
US
|
NASDAQ
|